ASKLEP Inc.   Report issue

For profit Phase 2
Founded: Tokyo Japan (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2013
NCT01813305
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now